Skip to main content

Lichter Jay's Form 4 filing

Janux Therapeutics, Inc. (JANX) · filed Sep 30, 2024

Accession no.
0001415889-24-024119
Filed
Sep 30, 2024, 8:49 PM ET
Trade date
Sep 26-30, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 22 non-derivative transactions and 8 derivative transactions. Open-market sales total $14.5M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lichter JayCIK 000137635510% Owner
Avalon Ventures XI, L.P.CIK 000165290110% Owner
Avalon BioVentures SPV I, L.P.CIK 000184455010% Owner
Avalon BioVentures I, LPCIK 000187393510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 26, 2024Common StockSSaleDisposed−49,497$46.78−$2,315,469.662,909,678Direct
Sep 26, 2024Common StockSSaleDisposed−9,592$46.78−$448,713.76563,635Indirect
Sep 26, 2024Common StockSSaleDisposed−50,539$46.78−$2,364,214.422,970,875Indirect
Sep 26, 2024Common StockSSaleDisposed−40,803$47.77−$1,949,159.312,868,875Direct
Sep 26, 2024Common StockSSaleDisposed−7,908$47.77−$377,765.16555,727Indirect
Sep 26, 2024Common StockSSaleDisposed−41,661$47.77−$1,990,145.972,929,214Indirect
Sep 27, 2024Common StockSSaleDisposed−45,894$46.42−$2,130,399.482,822,981Direct
Sep 27, 2024Common StockSSaleDisposed−8,894$46.42−$412,859.48546,833Indirect
Sep 27, 2024Common StockSSaleDisposed−46,861$46.42−$2,175,287.622,882,353Indirect
Sep 27, 2024Common StockSSaleDisposed−1,511$47.74−$72,135.142,821,470Direct
Sep 27, 2024Common StockSSaleDisposed−293$47.74−$13,987.82546,540Indirect
Sep 27, 2024Common StockSSaleDisposed−1,542$47.74−$73,615.082,880,811Indirect
Sep 27, 2024Common StockMOption exerciseAcquired+828$17.00+$14,0767,828Direct
Sep 27, 2024Common StockMOption exerciseAcquired+345$10.73+$3,701.858,173Direct
Sep 27, 2024Common StockMOption exerciseAcquired+345$13.22+$4,560.98,518Direct
Sep 27, 2024Common StockMOption exerciseAcquired+234$39.80+$9,313.28,752Direct
Sep 27, 2024Common StockSSaleDisposed−1,826$46.19−$84,342.946,926Direct
Sep 30, 2024Common StockMOption exerciseAcquired+434$17.00+$7,3787,360Direct
Sep 30, 2024Common StockMOption exerciseAcquired+181$10.73+$1,942.137,541Direct
Sep 30, 2024Common StockMOption exerciseAcquired+181$13.22+$2,392.827,722Direct
Sep 30, 2024Common StockMOption exerciseAcquired+123$39.80+$4,895.47,845Direct
Sep 30, 2024Common StockSSaleDisposed−958$46.24−$44,297.926,887Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 27, 2024Common StockMOption exerciseDisposed−828$0.00$028,178Direct
Sep 27, 2024Common StockMOption exerciseDisposed−345$0.00$011,741Direct
Sep 27, 2024Common StockMOption exerciseDisposed−345$0.00$011,741Direct
Sep 27, 2024Common StockMOption exerciseDisposed−234$0.00$07,839Direct
Sep 30, 2024Common StockMOption exerciseDisposed−434$0.00$027,744Direct
Sep 30, 2024Common StockMOption exerciseDisposed−181$0.00$011,560Direct
Sep 30, 2024Common StockMOption exerciseDisposed−181$0.00$011,560Direct
Sep 30, 2024Common StockMOption exerciseDisposed−123$0.00$07,716Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)